바이오테크네 (TECH) 주가

바이오테크네(TECH)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $72.40 (+0.32%), 시가총액 $7.00B, PER 63.91, 52주 범위 $44.74 ~ $71.38.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow

핵심 지표

• 현재가: $72.40 (+0.32%)
• 시가총액: $7.00B
• PER (주가수익비율): 63.91
• 52주 최저~최고: $44.74 ~ $71.38
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NASDAQ

바이오테크네의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

바이오테크네 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.1333

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 3.63
• 순이익률: 0.09%
• 영업이익률: 0.25%
• 배당수익률: 0.01%

자주 묻는 질문